Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
63M
-
Shares change
-
+867K
-
Total reported value, excl. options
-
$7.55B
-
Value change
-
+$116M
-
Put/Call ratio
-
1.21
-
Number of buys
-
168
-
Number of sells
-
-101
-
Price
-
$119.87
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2015
315 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2015.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63M shares
of 132M outstanding shares and own 47.87% of the company stock.
Largest 10 shareholders include FMR LLC (12.6M shares), WELLINGTON MANAGEMENT GROUP LLP (9.61M shares), VANGUARD GROUP INC (4.54M shares), Capital World Investors (2.06M shares), BlackRock Fund Advisors (1.78M shares), BlackRock Institutional Trust Company, N.A. (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.71M shares), FIRST TRUST ADVISORS LP (1.56M shares), GILDER GAGNON HOWE & CO LLC (1.51M shares), and STATE STREET CORP (1.47M shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.